Fibrobiologics

IN THE PRESS

Press Releases

FibroBiologics Advancing Development of a Fibroblast Treatment for Hantavirus

May 11, 2026

·

6 min read

Press Releases

FibroBiologics CEO Issues Letter to Shareholders - May 5, 2026

May 5, 2026

·

6 min read

Press Releases

FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring

May 4, 2026

·

6 min read

Press Releases

FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial

May 4, 2026

·

4 min read

Press Releases

FibroBiologics Reports Q1 2026 Financial Results and Provides Corporate Update

May 1, 2026

·

7 min read

Press Releases

FibroBiologics Announces Poster Presentation at the Society for Investigative Dermatology Annual Meeting 2026

April 30, 2026

·

1 min read

Press Releases

FibroBiologics Compliant with All Nasdaq Listing Requirements

April 21, 2026

·

3 min read

Press Releases

FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity

April 10, 2026

·

6 min read

Press Releases

FibroBiologics Announces Closing of $3 Million Public Offering

April 3, 2026

·

4 min read

Press Releases

FibroBiologics Announces Pricing of $3 Million Public Offering

April 1, 2026

·

5 min read

JOBS